午夜视频在线播放,久久久无码精品亚洲A片消消乐

香蕉91成人一区二区三区飘花,91精品人妻一区二区三区蜜桃,四川少妇BBw搡BBBB槡BBBB,国产成人91一区二区三区APP

<noscript id="ccccc"><optgroup id="ccccc"></optgroup></noscript>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

昏睡迷奷无码片免费A片 | 国产中韩高清无码2023 | 国产精品秘 ThePorn | 国产无码在线高清视频 | 富婆一区二区三区91 | 熟女人妻aⅴ一区二区三区60路 | 黄色视频免费看大全 | 特级小箩利无套内谢A片 | 天天婬欲婬香婬色婬视频播放 | 强伦轩一区二区三区四区播放方式 | 欧韩午夜色情A片影院 | 国产人妻精品一区二区三水牛影视 | 国产69精品久久久久熟女白洁 | 久久久久亚洲精品无码蜜桃 | 国产精品JIZZ在线观看99 | 国产精品一级毛片久久久网爆门 | 久久WWW免费人成精品 | 亚洲AⅤ无码一区二区波多野按摩 | 99视频在线观看国产 | 影音先锋女人aV鲁色资源网站 | 国产精品人妻无码久久久郑州天气网 | 久久精品国产亚洲AV香蕉喷水 | 国产一级A片无码免费下载樱花 | 国产精品一级毛片无码小说 | 嫩草成人影院红桃视频 | 国产裸体美女视频网站 | 寡妇愉情理伦片高潮 | 91成人黄区AAA级 | 女人自慰喷白浆A片免费下载 | 久久婷婷五月综合色国产香蕉 | 无码国产精品一区二区三 | 欧美掇BBBBB掇BBBBB| 国产做受18～20岁A片 | 婷婷五月天激情网 | 无套内射视频在线观看 | 少妇性色午夜婬片AAA片软件 | 女生自慰一级看片 | 亚洲无码中文字幕AV | 国产熟睡乱子伦午夜视频在线 | 东北女人毛多水多A片 | 国产无码AV一区二区 |

<nav id="c0cc0"><code id="c0cc0"></code></nav>

<noscript id="c0cc0"></noscript>